Vor Biopharma (VOR) EPS (Weighted Average and Diluted) (2021 - 2026)
Vor Biopharma (VOR) reported EPS (Weighted Average and Diluted) of -$5.11 for Q1 2026, up 1.92% year-over-year from -$5.01 in Q1 2025, and down 101.66% quarter-over-quarter from $307.61 in Q4 2025.
Vor Biopharma (VOR) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$5.11 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$5.11, up 1.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $168.31 (up 849.71% YoY), and the FY2025 annual result was -$70.5, down 107.17% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$5.11 in Q1 2026 per VOR's latest filing, from $307.61 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $307.61 in Q4 2025 and troughed at -$121.63 in Q3 2025.
- A 5-year average of $8.31 and a median of -$0.58 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 3603.53% in 2025 and fell as far as 2963.41% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.52 in 2022, then grew by 26.92% to -$0.38 in 2023, then sank by 2210.53% to -$8.78 in 2024, then jumped by 3603.53% to $307.61 in 2025, then plunged by 101.66% to -$5.11 in 2026.
- Business Quant data shows VOR's EPS (Weighted Average and Diluted) at -$5.11 in Q1 2026, $307.61 in Q4 2025, and -$121.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | -5.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.11 |
| Dec 31, 2025 | 307.61 |
| Sep 30, 2025 | -121.63 |
| Jun 30, 2025 | -12.56 |
| Mar 31, 2025 | -5.21 |
| Dec 31, 2024 | -8.78 |
| Sep 30, 2024 | -8.05 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -0.45 |
| Dec 31, 2023 | -0.38 |
| Sep 30, 2023 | -0.49 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.63 |
| Jun 30, 2022 | -0.58 |
| Mar 31, 2022 | -0.61 |
| Dec 31, 2021 | -0.48 |
| Sep 30, 2021 | -0.50 |
| Jun 30, 2021 | -0.50 |